CINV — Crucial Innovations Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Crucial Innovations, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.015 | -0.046 | -0.031 | -0.023 | -0.114 |
Depreciation | |||||
Non-Cash Items | — | 0 | 0.012 | — | 0.071 |
Unusual Items | |||||
Changes in Working Capital | 0.028 | 0.01 | 0.013 | -0.001 | 0.043 |
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Cash from Operating Activities | 0.013 | -0.034 | -0.006 | -0.024 | 0 |
Capital Expenditures | -0.014 | — | — | — | — |
Purchase of Fixed Assets | |||||
Cash from Investing Activities | -0.014 | — | — | — | — |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.001 | 0.034 | 0.006 | 0.024 | 0 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.001 | -0.001 | 0 | 0 | 0 |